Cargando…
Immunogenic cell death in cancer immunotherapy
Cancer immunotherapy has been acknowledged as a new paradigm for cancer treatment, with notable therapeutic effects on certain cancer types. Despite their significant potential, clinical studies over the past decade have revealed that cancer immunotherapy has low response rates in the majority of so...
Autores principales: | Choi, Minji, Shin, Jisoo, Lee, Chae-Eun, Chung, Joo-Yoon, Kim, Minji, Yan, Xiuwen, Yang, Wen-Hao, Cha, Jong-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230015/ https://www.ncbi.nlm.nih.gov/pubmed/37081756 http://dx.doi.org/10.5483/BMBRep.2023-0024 |
Ejemplares similares
-
A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity
por: Kim, KyeongJin, et al.
Publicado: (2020) -
Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
por: Kim, Ji-Hae, et al.
Publicado: (2021) -
Update of early phase clinical trials in cancer immunotherapy
por: Lee, Dae Ho
Publicado: (2021) -
Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors
por: Kim, Nayoung, et al.
Publicado: (2021) -
Mucin in cancer: a stealth cloak for cancer cells
por: Wi, Dong-Han, et al.
Publicado: (2021)